학술대회안내사전등록초록등록안내초록등록/관리숙박 및 교통
초록심사

мȸ ǥ ʷ

ǥ : ȣ - 480088   35 
Relation between Serum Markers of Myocardial Fibrosis and Coronary Flow Reserve in Arterial Hypertension
가톨릭 의대 순환기 내과¹
윤호중¹, 임상현,¹ 김지훈,¹ 박철수,¹ 이종민,¹ 조은주,¹ 전희경,¹ 정해억,¹ 오용석,¹ 정욱성,¹ 승기배,¹ 김재형, ¹ 최규보,¹ 홍순조¹
Purpose: The purpose of this study was to evaluate the relation between serum markers of myocardial fibrosis and coronary flow reserve (CFR) using transthoracic Doppler echocardiography (TTE) in patients with arterial hypertension. Methods: In fifty-eight subjects (M:F= 31:27, mean age 57±9 years) with chest pain and normal coronary angiogram, CFR was estimated with TTE and adenosine(140 μg/kg/min) and serum PIP (carboxy-terminal propeptide of procollagen type I), TGF-β(trasforming growth factor-β), MMP-3 (metalloproteinase 3) and TIMP-1(tissue inhibitor of metalloproteinase 1) were measured as serum markers of myocardial fibrosis. The subjects were divided into 3 groups: 19 hypertensives with CFR < 2.0 (group A, mean CFR=1.88±0.43) 23 hypertensives with CFR ≥2.0 (group B, mean CFR=2.90±0.50) and 16 normotensives with CFR≥ 2.0 (group C, mean CFR=3.09±0.70). Patients with a history of acute myocardial infarction, regional wall motion abnormalities, wall thickness more than 12 mm of interventricular septum and posterior wall,left ventricular ejection fraction less than 55%, or primary valvular heart disease were excluded from this study. Results: 1.Baseline coronary flow velocity was 28.9±17.0 cm/s in group A, 16.9±5.5 cm/s in group B and 14.6±4.1 cm/s in group C(0.005 versus group B and group C). 2. Serum PIP was 131.35±31.76 μg/L in group A, 107.66±26.04 μg/L in group B, and 90.10±22.35 μg/L in group C (p<0.0001 versus group B and group C. 3. There were no significant differences in serum TGF-β, MMP3 and TIMP1 levels among 3 groups. 4. Serum PIP in group C was closely related to CFR(r=0.67, p=0.0043). 5. A cutoff of 120 μg/L for PIP provided 59 % sensitivity and 74% specificity for predicting CFR<2.0 in hypertensives. Conclusion: This results show a relation between the severity of myocardial fibrosis and CFR in hypertension. Thus, the measurement of PIP may be useful for the elucidation of the mechanism causing impaired CFR in hypertensive patients with chest pain and normal coronary angiogram.


[ư]